Fingerprint
Dive into the research topics of 'HER2,TOP2A, and TIMP-1 and responsiveness to adjuvant anthracycline-containing chemotherapy in high-risk breast cancer patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
HER2,TOP2A, and TIMP-1 and responsiveness to adjuvant anthracycline-containing chemotherapy in high-risk breast cancer patients
Bent Ejlertsen, Maj-Britt Jensen, Kirsten V. Nielsen, Eva Balslev, Birgitte B. Rasmussen, Gro L. Willemoe, Pernille Bræmer Hertel, Ann S. Knoop, Henning T. Mouridsen , Nils Brunner